# Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults

> **NCT04013477** · PHASE1 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DA-5207
- **DRUG:** Donepezil Hydrochloride

## Key facts

- **NCT ID:** NCT04013477
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-18
- **Primary completion:** 2019-12-05
- **Final completion:** 2020-04-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04013477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04013477, "Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04013477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*